Search research articles
Contact Us
Filters
Showing results (261-270 of 359) with videos related to
Page
of 36
Sort By:
Multiple Sclerosis and Related Disorders
|
October 21, 2018
Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study
Robert Zivadinov, Jennie Medin, Nasreen Khan, et al.
AJNR. American Journal of Neuroradiology
|
November 24, 2018
Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine
E Ghione, N Bergsland, M G Dwyer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 22, 2009
Brain atrophy and white matter hyperintensities in early Parkinson's disease(a)
Turi O Dalaker, Jan P Larsen, Niels Bergsland, et al.
Neurobiology of Aging
|
March 10, 2020
Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls
Dejan Jakimovski, Niels Bergsland, Michael G Dwyer, et al.
Human Brain Mapping
|
April 22, 2025
Sensitivity of Quantitative Susceptibility Mapping for Clinical Research in Deep Gray Matter
Fahad Salman, Abhisri Ramesh, Thomas Jochmann, et al.
Genetics
|
January 12, 2013
Molecular characterization and evolution of self-incompatibility genes in Arabidopsis thaliana: the case of the Sc haplotype
Kathleen G Dwyer, Martin T Berger, Rimsha Ahmed, et al.
Arxiv
|
February 20, 2025
Sensitivity of Quantitative Susceptibility Mapping in Clinical Brain Research
Fahad Salman, Abhisri Ramesh, Thomas Jochmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 25, 2015
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
Yazhong Tao, Xin Zhang, Robert Zivadinov, et al.
Frontiers in Bioscience (Elite Edition)
|
January 2, 2013
Gray matter SWI-filtered phase and atrophy are linked to disability in MS
Jesper Hagemeier, Bianca Weinstock-Guttman, Mari Heininen-Brown, et al.
Annals of Clinical and Translational Neurology
|
January 18, 2024
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
Kian Jalaleddini, Dejan Jakimovski, Anisha Keshavan, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 359) with videos related to
Sort By:
Page
of 36
Multiple Sclerosis and Related Disorders
|
October 21, 2018
Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study
Robert Zivadinov, Jennie Medin, Nasreen Khan, et al.
AJNR. American Journal of Neuroradiology
|
November 24, 2018
Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine
E Ghione, N Bergsland, M G Dwyer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 22, 2009
Brain atrophy and white matter hyperintensities in early Parkinson's disease(a)
Turi O Dalaker, Jan P Larsen, Niels Bergsland, et al.
Neurobiology of Aging
|
March 10, 2020
Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls
Dejan Jakimovski, Niels Bergsland, Michael G Dwyer, et al.
Human Brain Mapping
|
April 22, 2025
Sensitivity of Quantitative Susceptibility Mapping for Clinical Research in Deep Gray Matter
Fahad Salman, Abhisri Ramesh, Thomas Jochmann, et al.
Genetics
|
January 12, 2013
Molecular characterization and evolution of self-incompatibility genes in Arabidopsis thaliana: the case of the Sc haplotype
Kathleen G Dwyer, Martin T Berger, Rimsha Ahmed, et al.
Arxiv
|
February 20, 2025
Sensitivity of Quantitative Susceptibility Mapping in Clinical Brain Research
Fahad Salman, Abhisri Ramesh, Thomas Jochmann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 25, 2015
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
Yazhong Tao, Xin Zhang, Robert Zivadinov, et al.
Frontiers in Bioscience (Elite Edition)
|
January 2, 2013
Gray matter SWI-filtered phase and atrophy are linked to disability in MS
Jesper Hagemeier, Bianca Weinstock-Guttman, Mari Heininen-Brown, et al.
Annals of Clinical and Translational Neurology
|
January 18, 2024
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
Kian Jalaleddini, Dejan Jakimovski, Anisha Keshavan, et al.
Page
of 36